The FDA Continues to Work on CBD Products Focusing on Protecting Public Health
The FDA is continuing to work on studying and clarifying rules and regulations for Cannabidiol (CBD) products.
Their main focus is on educating the public about the risks and unknowns of these products by gathering the science needed to better understand both the safety concerns and potential benefits. They are also taking steps when necessary to address products that violate the law in ways that raise a variety of public health concerns.
The FDA recognizes the significant public interest in CBD and they understand that they must work together with stakeholders and industry to develop high-quality data to close the substantial knowledge gaps about the science, safety and quality of many of these products.
The FDA is committed to working efficiently to further clarify its regulatory approach to CBD products.
To read the full article Click Here
Now is the time to be a leader in the CBD industry. Get Certified!
